Benjamin Thorp
-
Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards synthetic genetically engineered alternatives. -
The attorneys general sent a letter saying the FDA needs to take action because high demand for the weight loss drugs paired with shortages has created a market for counterfeits.
